CLEC10A and cancer: Ahn and Kim (2009) together with Liang et al. (2009) reported increased expression of HERV-H, HERV-R.3-1, and HERV-P in overall liver cancers without taking into consideration distinct cancer subtypes [236,237], while several other groups reported the distinct activation of HERV-K (HML-2) and HERV-P in hepatocellular carcinomas (HCCs) specifically [238,239].